The SURPASS Trial

A Clinical Research Study for Type 2 Diabetes With Cardiovascular Disease

If you are living with type 2 diabetes, it’s time to talk about your increased risk of cardiovascular events.

Currently, the SURPASS-CVOT study is underway evaluating an investigational medication and its potential to prevent major adverse cardiovascular events in those with type 2 diabetes.

In Order to Qualify, You Must:

  • Be at least 40 years of age
  • Be diagnosed with type 2 diabetes
  • Have an established cardiovascular disease*

* coronary artery disease, cerebrovascular disease, or peripheral arterial disease

Health insurance is not required. All study-related care is provided at no cost.

Call 1-888-123-4567
or visit www.surpasscvotstudy.com